Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,8.031727594563402e-58,56.654970760233915,7448.232738655868,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.441645188747274e-55,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.559934998136921e-36,26.601584606677985,2180.08183079398,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",3.89110119716812e-34,0,0,51
3,Oxidative phosphorylation WP623,1.539010878874242e-21,24.75558867362146,1186.365715801573,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.5595310239258983e-19,0,0,30
4,Nonalcoholic fatty liver disease WP4396,5.3624727124676645e-20,8.99159990666563,398.9777587125767,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'PPARA']",4.075479261475425e-18,0,0,42
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.0766587005344733e-11,11.898924731182795,300.50227006657457,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",6.546084899249598e-10,0,0,20
6,Mitochondrial CIV Assembly WP4922,1.7248545595649455e-09,13.2912,268.1914697907582,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'COX20']",8.739263101795724e-08,0,0,15
7,Mitochondrial complex III assembly WP4921,0.0006393326727825006,8.741324921135647,64.29319326544837,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.02776530464655431,0,0,6
8,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.003072415792251834,11.624737945492662,67.25249325273708,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.11675180010556968,0,0,4
9,Translation Factors WP107,0.00749512808368203,3.3315250150693188,16.302824518707926,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.253168770826593,0,0,8
10,Cellular Proteostasis WP4918,0.01733592904312827,8.70486656200942,35.29800852073634,"['VBP1', 'PFDN4', 'PFDN6']",0.5270122429110994,0,0,3
11,Base Excision Repair WP4752,0.02509515807760256,3.6325459317585302,13.386223658034892,"['POLE4', 'NEIL2', 'MPG', 'TDG', 'POLD2']",0.6555547048112957,0,0,5
12,Synaptic Vesicle Pathway WP2267,0.026008818907210445,3.079049916496567,11.236437239618564,"['SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1']",0.6555547048112957,0,0,6
13,Glycolysis in senescence WP5049,0.028033589350483043,6.527472527472527,23.331483622644384,"['LDHA', 'ALDOC', 'HK1']",0.6555547048112957,0,0,3
14,Proteasome Degradation WP183,0.05552882647846541,2.2612486103797322,6.536937322415776,"['PSMB6', 'PSMC5', 'PSMB5', 'PSMB3', 'PSMC1', 'HLA-B', 'PSMB10']",0.9934955304449842,0,0,7
15,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.055618240907314556,8.692789968652038,25.11559176139264,"['GSTP1', 'COX5A']",0.9934955304449842,0,0,2
16,Glutathione metabolism WP100,0.055618240907314556,8.692789968652038,25.11559176139264,"['GPX4', 'GSS']",0.9934955304449842,0,0,2
17,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.06958014667431926,2.561834182491894,6.827995165816428,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9934955304449842,0,0,5
18,DNA Repair Pathways Full Network WP4946,0.07870751731686734,1.9381153305203938,4.926721361273904,"['POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'MPG', 'TDG', 'POLD2', 'GTF2H5']",0.9934955304449842,0,0,8
19,Selenium Micronutrient Network WP15,0.09482540939901972,2.2913385826771653,5.397747254598409,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOH']",0.9934955304449842,0,0,5
20,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.09682648130158342,3.26138147566719,7.614786818528616,"['MDH2', 'IDH3G', 'IDH3A']",0.9934955304449842,0,0,3
21,15q11.2 copy number variation syndrome WP4940,0.10342573190549967,inf,inf,['TUBGCP4'],0.9934955304449842,0,0,1
22,Glucuronidation WP698,0.10342573190549967,inf,inf,['HK1'],0.9934955304449842,0,0,1
23,Pyrimidine metabolism WP4022,0.1374974686451507,1.7418641390205372,3.4561193341156433,"['POLE4', 'POLR3GL', 'POLD2', 'ENPP1', 'NME3', 'POLR2I', 'POLR2K']",0.9934955304449842,0,0,7
24,7q11.23 copy number variation syndrome WP4932,0.1395872962731849,1.6594333936106087,3.267532370683954,"['ATP5F1A', 'ATP5F1B', 'ATP5MC2', 'ATP5PO', 'SQSTM1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.9934955304449842,0,0,8
25,Ferroptosis WP4313,0.14519598750614707,2.1745283018867925,4.196123792341132,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2']",0.9934955304449842,0,0,4
26,Modulators of TCR signaling and T cell activation WP5072,0.14519598750614707,2.1745283018867925,4.196123792341132,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9934955304449842,0,0,4
27,Type II diabetes mellitus WP1584,0.1581765710445965,3.475235109717868,6.40848413009291,"['SURF1', 'PRKCD']",0.9934955304449842,0,0,2
28,Nanomaterial induced apoptosis WP2507,0.1581765710445965,3.475235109717868,6.40848413009291,"['ENDOG', 'CYCS']",0.9934955304449842,0,0,2
29,Small Ligand GPCRs WP247,0.19616966875546213,8.68075117370892,14.138993420982537,['LPAR1'],0.9934955304449842,0,0,1
30,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.19616966875546213,8.68075117370892,14.138993420982537,['VIP'],0.9934955304449842,0,0,1
31,EV release from cardiac cells and their functional effects WP3297,0.19616966875546213,8.68075117370892,14.138993420982537,['ERBB4'],0.9934955304449842,0,0,1
32,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.19616966875546213,8.68075117370892,14.138993420982537,['GSS'],0.9934955304449842,0,0,1
33,Gastric acid production WP2596,0.19616966875546213,8.68075117370892,14.138993420982537,['VIP'],0.9934955304449842,0,0,1
34,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.19616966875546213,8.68075117370892,14.138993420982537,['ELOB'],0.9934955304449842,0,0,1
35,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.19616966875546213,8.68075117370892,14.138993420982537,['BLVRB'],0.9934955304449842,0,0,1
36,let-7 inhibition of ES cell reprogramming WP3299,0.19616966875546213,8.68075117370892,14.138993420982537,['SOX2'],0.9934955304449842,0,0,1
37,"Phase I biotransformations, non P450 WP136",0.19616966875546213,8.68075117370892,14.138993420982537,['CES2'],0.9934955304449842,0,0,1
38,DNA Mismatch Repair WP531,0.1970798210660175,2.8955067920585162,4.702727075050175,"['POLE4', 'POLD2']",0.9934955304449842,0,0,2
39,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.1970798210660175,2.8955067920585162,4.702727075050175,"['FGF1', 'GTPBP4']",0.9934955304449842,0,0,2
40,CAMKK2  Pathway WP4874,0.1972384572823936,2.172684458398744,3.5270095846589,"['FIS1', 'MAP1LC3A', 'SQSTM1']",0.9934955304449842,0,0,3
41,Glycolysis and Gluconeogenesis WP534,0.20907509846901062,1.830188679245283,2.864358331467688,"['LDHA', 'MDH2', 'ALDOC', 'HK1']",0.9934955304449842,0,0,4
42,Exercise-induced Circadian Regulation WP410,0.2319250379935107,1.738364779874214,2.540343850296062,"['DAZAP2', 'HSPA8', 'SUMO1', 'GSTP1']",0.9934955304449842,0,0,4
43,Computational Model of Aerobic Glycolysis WP4629,0.23695071099946352,2.4814151365875503,3.5729974218585165,"['LDHA', 'HK1']",0.9934955304449842,0,0,2
44,Cori Cycle WP1946,0.23695071099946352,2.4814151365875503,3.5729974218585165,"['LDHA', 'HK1']",0.9934955304449842,0,0,2
45,Neural Crest Cell Migration during Development WP4564,0.23695071099946352,2.4814151365875503,3.5729974218585165,"['CDH11', 'EPHB3']",0.9934955304449842,0,0,2
46,Wnt signaling pathway and pluripotency WP399,0.2553447978376008,1.65528601377658,2.2596979744545864,"['SOX2', 'PRKCG', 'PRKCD', 'DVL3']",0.9934955304449842,0,0,4
47,Cell migration and invasion through p75NTR WP4561,0.27717407968003516,2.170846394984326,2.7854336838644222,"['EFNB2', 'CDH11']",0.9934955304449842,0,0,2
48,Type II interferon signaling (IFNG) WP619,0.27717407968003516,2.170846394984326,2.7854336838644222,"['PRKCD', 'HLA-B']",0.9934955304449842,0,0,2
49,Neural Crest Cell Migration in Cancer WP4565,0.27717407968003516,2.170846394984326,2.7854336838644222,"['CDH11', 'EPHB3']",0.9934955304449842,0,0,2
50,Cytosine methylation WP3585,0.27933338506131816,4.339593114241001,5.534496962351986,['TDG'],0.9934955304449842,0,0,1
51,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.27933338506131816,4.339593114241001,5.534496962351986,['PPARA'],0.9934955304449842,0,0,1
52,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.27933338506131816,4.339593114241001,5.534496962351986,['PPARA'],0.9934955304449842,0,0,1
53,Homologous recombination WP186,0.27933338506131816,4.339593114241001,5.534496962351986,['POLD2'],0.9934955304449842,0,0,1
54,Irinotecan pathway WP229,0.27933338506131816,4.339593114241001,5.534496962351986,['CES2'],0.9934955304449842,0,0,1
55,Non-homologous end joining WP438,0.27933338506131816,4.339593114241001,5.534496962351986,['DCLRE1C'],0.9934955304449842,0,0,1
56,Cytosolic DNA-sensing pathway WP4655,0.28346274656367626,1.7372056514913659,2.19005098746598,"['IRF3', 'POLR3GL', 'POLR2K']",0.9934955304449842,0,0,3
57,GABA receptor Signaling WP4159,0.28346274656367626,1.7372056514913659,2.19005098746598,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9934955304449842,0,0,3
58,Fluoropyrimidine Activity WP1601,0.31725132014635915,1.9292929292929293,2.214945991263493,"['TDG', 'CES2']",0.9934955304449842,0,0,2
59,mRNA Processing WP411,0.32496179047646095,1.264211737629459,1.4210342597488868,"['LSM7', 'SF3A1', 'CELF1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'SRSF9']",0.9934955304449842,0,0,8
60,Nucleotide Excision Repair WP4753,0.3426253273706973,1.5322744482408348,1.6412463883138622,"['POLE4', 'POLD2', 'GTF2H5']",0.9934955304449842,0,0,3
61,ACE Inhibitor Pathway WP554,0.35390508899238354,2.8925404277516953,3.004558429300865,['ATP6AP2'],0.9934955304449842,0,0,1
62,"Cerebral organic acidurias, including diseases WP4519",0.35390508899238354,2.8925404277516953,3.004558429300865,['MDH2'],0.9934955304449842,0,0,1
63,Dopaminergic Neurogenesis WP2855,0.35390508899238354,2.8925404277516953,3.004558429300865,['SOX2'],0.9934955304449842,0,0,1
64,Dual hijack model of Vif in HIV infection WP3300,0.35390508899238354,2.8925404277516953,3.004558429300865,['ELOB'],0.9934955304449842,0,0,1
65,Estrogen Receptor Pathway WP2881,0.35390508899238354,2.8925404277516953,3.004558429300865,['PPARA'],0.9934955304449842,0,0,1
66,Galanin receptor pathway WP4970,0.35390508899238354,2.8925404277516953,3.004558429300865,['PRKCD'],0.9934955304449842,0,0,1
67,Matrix Metalloproteinases WP129,0.35390508899238354,2.8925404277516953,3.004558429300865,['MMP16'],0.9934955304449842,0,0,1
68,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.35390508899238354,2.8925404277516953,3.004558429300865,['VEGFB'],0.9934955304449842,0,0,1
69,miR-509-3p alteration of YAP1/ECM axis WP3967,0.35390508899238354,2.8925404277516953,3.004558429300865,['COL5A1'],0.9934955304449842,0,0,1
70,Mitochondrial fatty acid synthesis pathway WP4317,0.35390508899238354,2.8925404277516953,3.004558429300865,['HSD17B12'],0.9934955304449842,0,0,1
71,Allograft Rejection WP2328,0.35678290888536285,1.736050156739812,1.7892215199288566,"['COL5A1', 'HLA-B']",0.9934955304449842,0,0,2
72,White fat cell differentiation WP4149,0.35678290888536285,1.736050156739812,1.7892215199288566,"['IRF3', 'DDIT3']",0.9934955304449842,0,0,2
73,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.35678290888536285,1.736050156739812,1.7892215199288566,"['LDHA', 'RPS6']",0.9934955304449842,0,0,2
74,Notch Signaling WP268,0.35678290888536285,1.736050156739812,1.7892215199288566,"['APH1A', 'DVL3']",0.9934955304449842,0,0,2
75,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.35678290888536285,1.736050156739812,1.7892215199288566,"['NDUFA13', 'AAMP']",0.9934955304449842,0,0,2
76,SARS-CoV-2 mitochondrial interactions WP5038,0.35678290888536285,1.736050156739812,1.7892215199288566,"['NDUFB9', 'IRF3']",0.9934955304449842,0,0,2
77,Complement system WP2806,0.3954532937360133,1.5779424337418069,1.4638928461852503,"['RPS19', 'CD59']",0.9934955304449842,0,0,2
78,PKC-gamma calcium signaling pathway in ataxia WP4760,0.3954532937360133,1.5779424337418069,1.4638928461852503,"['PRKCG', 'TRPC3']",0.9934955304449842,0,0,2
79,Pre-implantation embryo WP3527,0.3954532937360133,1.5779424337418069,1.4638928461852503,"['SOX2', 'DDIT3']",0.9934955304449842,0,0,2
80,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.40137594753821815,1.370486656200942,1.2510580166129248,"['OTUD5', 'IRF3', 'PIN1']",0.9934955304449842,0,0,3
81,Ciliary landscape WP4352,0.40725628912826345,1.1239689516506126,1.0096754585773158,"['MYL6', 'NDUFA5', 'WNK1', 'SSNA1', 'DVL3', 'COPS7A', 'MYL6B', 'SNRPB2', 'COX6C', 'DCAF11', 'LSM4']",0.9934955304449842,0,0,11
82,Serotonin and anxiety-related events WP3944,0.4207712095100149,2.1690140845070425,1.8776418296911042,['CRH'],0.9934955304449842,0,0,1
83,Apoptosis Modulation by HSP70 WP384,0.4207712095100149,2.1690140845070425,1.8776418296911042,['CYCS'],0.9934955304449842,0,0,1
84,Aspirin and miRNAs WP4707,0.4207712095100149,2.1690140845070425,1.8776418296911042,['PPARA'],0.9934955304449842,0,0,1
85,Transcriptional cascade regulating adipogenesis WP4211,0.4207712095100149,2.1690140845070425,1.8776418296911042,['DDIT3'],0.9934955304449842,0,0,1
86,Cysteine and methionine catabolism WP4504,0.4207712095100149,2.1690140845070425,1.8776418296911042,['GSS'],0.9934955304449842,0,0,1
87,Genes targeted by miRNAs in adipocytes WP1992,0.4207712095100149,2.1690140845070425,1.8776418296911042,['TMSB4X'],0.9934955304449842,0,0,1
88,Heart Development WP1591,0.4207712095100149,2.1690140845070425,1.8776418296911042,['VEGFB'],0.9934955304449842,0,0,1
89,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4207712095100149,2.1690140845070425,1.8776418296911042,['RPS6'],0.9934955304449842,0,0,1
90,Insulin signaling in adipocytes (normal condition) WP3634,0.4207712095100149,2.1690140845070425,1.8776418296911042,['RPS6'],0.9934955304449842,0,0,1
91,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.4207712095100149,2.1690140845070425,1.8776418296911042,['ERBB4'],0.9934955304449842,0,0,1
92,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4207712095100149,2.1690140845070425,1.8776418296911042,['IRF3'],0.9934955304449842,0,0,1
93,Alzheimer's disease WP2059,0.4255424685292265,1.2398921832884098,1.0593521364236282,"['ATP5MD', 'APH1A', 'CHP1', 'CYCS']",0.9934955304449842,0,0,4
94,Amino Acid metabolism WP3925,0.4255424685292265,1.2398921832884098,1.0593521364236282,"['LDHA', 'MDH2', 'GSS', 'ODC1']",0.9934955304449842,0,0,4
95,Eukaryotic Transcription Initiation WP405,0.43022106497317475,1.3017268445839874,1.0979494447502487,"['TAF13', 'POLR2I', 'POLR2K']",0.9934955304449842,0,0,3
96,Metabolic reprogramming in colon cancer WP4290,0.43022106497317475,1.3017268445839874,1.0979494447502487,"['LDHA', 'MDH2', 'IDH3A']",0.9934955304449842,0,0,3
97,Unfolded protein response WP4925,0.433017840847469,1.446185997910136,1.2104234764297817,"['DDIT3', 'EIF2S1']",0.9934955304449842,0,0,2
98,DNA Replication WP466,0.433017840847469,1.446185997910136,1.2104234764297817,"['POLD2', 'UBA52']",0.9934955304449842,0,0,2
99,Metapathway biotransformation Phase I and II WP702,0.44173346924339835,1.1728027239838263,0.9582368114514921,"['CYP4Z1', 'GPX4', 'GSTO1', 'GSTP1', 'GSS']",0.9934955304449842,0,0,5
100,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.458549057551457,1.2395155864543619,0.9664354251740103,"['PRKCG', 'IFI27L2', 'PRKCD']",0.9934955304449842,0,0,3
101,Parkinson's disease pathway WP2371,0.4692915766508438,1.334699782975645,1.0097417683139898,"['CYCS', 'PARK7']",0.9934955304449842,0,0,2
102,MAPK Signaling Pathway WP382,0.4782169886291785,1.06973058637084,0.7891303033471722,"['PRKCG', 'DUSP4', 'HSPA8', 'DUSP3', 'DDIT3', 'PRKCD', 'FGF1', 'RASGRP2', 'NGF']",0.9934955304449842,0,0,9
103,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4807268544887777,1.7348982785602505,1.270736723370494,['IRF3'],0.9934955304449842,0,0,1
104,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4807268544887777,1.7348982785602505,1.270736723370494,['SST'],0.9934955304449842,0,0,1
105,Thiamine metabolic pathways WP4297,0.4807268544887777,1.7348982785602505,1.270736723370494,['BCKDK'],0.9934955304449842,0,0,1
106,Wnt signaling in kidney disease WP4150,0.4807268544887777,1.7348982785602505,1.270736723370494,['DVL3'],0.9934955304449842,0,0,1
107,HIF1A and PPARG regulation of glycolysis WP2456,0.4807268544887777,1.7348982785602505,1.270736723370494,['LDHA'],0.9934955304449842,0,0,1
108,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.4807268544887777,1.7348982785602505,1.270736723370494,['MAP1LC3A'],0.9934955304449842,0,0,1
109,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.4807268544887777,1.7348982785602505,1.270736723370494,['SQSTM1'],0.9934955304449842,0,0,1
110,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4807268544887777,1.7348982785602505,1.270736723370494,['ERBB4'],0.9934955304449842,0,0,1
111,Nanoparticle triggered autophagic cell death WP2509,0.4807268544887777,1.7348982785602505,1.270736723370494,['MAP1LC3A'],0.9934955304449842,0,0,1
112,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4807268544887777,1.7348982785602505,1.270736723370494,['LDHA'],0.9934955304449842,0,0,1
113,PPAR-alpha pathway WP2878,0.4807268544887777,1.7348982785602505,1.270736723370494,['PPARA'],0.9934955304449842,0,0,1
114,Glycogen Synthesis and Degradation WP500,0.5041394950567879,1.239140170174653,0.848689919489756,"['PHKG1', 'HK1']",0.9934955304449842,0,0,2
115,Histone Modifications WP2369,0.5041394950567879,1.239140170174653,0.848689919489756,"['SET', 'SETDB2']",0.9934955304449842,0,0,2
116,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5041394950567879,1.239140170174653,0.848689919489756,"['PRKCG', 'PRKCD']",0.9934955304449842,0,0,2
117,One-carbon metabolism and related pathways WP3940,0.5041394950567879,1.239140170174653,0.848689919489756,"['GPX4', 'GSS']",0.9934955304449842,0,0,2
118,Acute viral myocarditis WP4298,0.5132648284437732,1.1313220940550133,0.7545503536780714,"['ENDOG', 'CYCS', 'DMD']",0.9934955304449842,0,0,3
119,Signal Transduction of S1P Receptor WP26,0.5344852039350554,1.4454877412623892,0.9055275748621706,['ASAH1'],0.9934955304449842,0,0,1
120,Cell Differentiation - Index expanded WP2023,0.5344852039350554,1.4454877412623892,0.9055275748621706,['SOX2'],0.9934955304449842,0,0,1
121,Urea cycle and associated pathways WP4595,0.5344852039350554,1.4454877412623892,0.9055275748621706,['MDH2'],0.9934955304449842,0,0,1
122,Urea cycle and metabolism of amino groups WP497,0.5344852039350554,1.4454877412623892,0.9055275748621706,['ODC1'],0.9934955304449842,0,0,1
123,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5344852039350554,1.4454877412623892,0.9055275748621706,['ENPP1'],0.9934955304449842,0,0,1
124,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.5344852039350554,1.4454877412623892,0.9055275748621706,['GRM7'],0.9934955304449842,0,0,1
125,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5344852039350554,1.4454877412623892,0.9055275748621706,['EIF2AK1'],0.9934955304449842,0,0,1
126,Mitochondrial Gene Expression WP391,0.5344852039350554,1.4454877412623892,0.9055275748621706,['PPRC1'],0.9934955304449842,0,0,1
127,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5344852039350554,1.4454877412623892,0.9055275748621706,['MDH2'],0.9934955304449842,0,0,1
128,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.5344852039350554,1.4454877412623892,0.9055275748621706,['PPARA'],0.9934955304449842,0,0,1
129,SARS coronavirus and innate immunity WP4912,0.5344852039350554,1.4454877412623892,0.9055275748621706,['IRF3'],0.9934955304449842,0,0,1
130,Wnt Signaling Pathway WP363,0.5374682262990602,1.1563218390804597,0.7179436188475458,"['PRKCG', 'DVL3']",0.9934955304449842,0,0,2
131,Energy Metabolism WP1541,0.5374682262990602,1.1563218390804597,0.7179436188475458,"['PPRC1', 'PPARA']",0.9934955304449842,0,0,2
132,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5476890001478005,0.9936920146640179,0.5982499632309338,"['RPL5', 'SET', 'TRPC3', 'PRKCD', 'RPS6', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'CCT7', 'EIF3D', 'PTMA']",0.9934955304449842,0,0,18
133,Genotoxicity pathway WP4286,0.5692188907387513,1.0838557993730407,0.6107421483540951,"['RPS27', 'PHLDA3']",0.9934955304449842,0,0,2
134,IL-6 signaling pathway WP364,0.5692188907387513,1.0838557993730407,0.6107421483540951,"['PRKCD', 'VIP']",0.9934955304449842,0,0,2
135,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5692188907387513,1.0838557993730407,0.6107421483540951,"['LDHA', 'HK1']",0.9934955304449842,0,0,2
136,Serotonin and anxiety WP3947,0.582685939409042,1.238765928906774,0.669066069283121,['CRH'],0.9934955304449842,0,0,1
137,Sleep regulation WP3591,0.582685939409042,1.238765928906774,0.669066069283121,['CRH'],0.9934955304449842,0,0,1
138,Striated Muscle Contraction Pathway WP383,0.582685939409042,1.238765928906774,0.669066069283121,['DMD'],0.9934955304449842,0,0,1
139,Trans-sulfuration and one-carbon metabolism WP2525,0.582685939409042,1.238765928906774,0.669066069283121,['GSS'],0.9934955304449842,0,0,1
140,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.582685939409042,1.238765928906774,0.669066069283121,['IRF3'],0.9934955304449842,0,0,1
141,Zinc homeostasis WP3529,0.582685939409042,1.238765928906774,0.669066069283121,['SLC30A3'],0.9934955304449842,0,0,1
142,miRNA regulation of p53 pathway in prostate cancer WP3982,0.582685939409042,1.238765928906774,0.669066069283121,['SHISA5'],0.9934955304449842,0,0,1
143,Pathways in clear cell renal cell carcinoma WP4018,0.5846517630991755,0.9906558849955076,0.5317235358755337,"['LDHA', 'ALDOC', 'SQSTM1', 'HK1']",0.9934955304449842,0,0,4
144,Development of ureteric collection system WP5053,0.5993609819054921,1.0199151761017886,0.5220856252916851,"['ROBO2', 'GDF11']",0.9934955304449842,0,0,2
145,Regulation of toll-like receptor signaling pathway WP1449,0.6052522359778462,0.9629629629629629,0.4835133226119103,"['OTUD5', 'IRF3', 'SQSTM1', 'RNF41']",0.9934955304449842,0,0,4
146,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.6259028077966355,1.0837245696400626,0.5077901783879507,['PPARA'],0.9934955304449842,0,0,1
147,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6259028077966355,1.0837245696400626,0.5077901783879507,['CYCS'],0.9934955304449842,0,0,1
148,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6259028077966355,1.0837245696400626,0.5077901783879507,['RPS6'],0.9934955304449842,0,0,1
149,Hippo-Yap signaling pathway WP4537,0.6259028077966355,1.0837245696400626,0.5077901783879507,['TNIK'],0.9934955304449842,0,0,1
150,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6259028077966355,1.0837245696400626,0.5077901783879507,['B3GALT2'],0.9934955304449842,0,0,1
151,MTHFR deficiency WP4288,0.6259028077966355,1.0837245696400626,0.5077901783879507,['CYCS'],0.9934955304449842,0,0,1
152,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6259028077966355,1.0837245696400626,0.5077901783879507,['OMG'],0.9934955304449842,0,0,1
153,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6259028077966355,1.0837245696400626,0.5077901783879507,['GSTP1'],0.9934955304449842,0,0,1
154,Pregnane X receptor pathway WP2876,0.6259028077966355,1.0837245696400626,0.5077901783879507,['PSMC5'],0.9934955304449842,0,0,1
155,Regulation of Microtubule Cytoskeleton WP2038,0.6278871429479433,0.9630790665273424,0.4482120255169606,"['PARD6A', 'MAPRE1']",0.9934955304449842,0,0,2
156,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6357325836024468,0.9284592958062345,0.4205709572100571,"['PRKCG', 'RPS6', 'PDGFC']",0.9934955304449842,0,0,3
157,EGF/EGFR signaling pathway WP437,0.6362642013413775,0.9215949070196012,0.41669120318649283,"['NDUFA13', 'PRKCD', 'AP2S1', 'NEDD8', 'AP2M1']",0.9934955304449842,0,0,5
158,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6548087171626785,0.9122257053291536,0.38624742059962835,"['ERBB4', 'TMSB4X']",0.9934955304449842,0,0,2
159,MECP2 and Associated Rett Syndrome WP3584,0.6574763699978273,0.8962810588426352,0.3758522844788244,"['BCL6', 'SST', 'RPS6']",0.9934955304449842,0,0,3
160,Osteoblast differentiation WP4787,0.6574763699978273,0.8962810588426352,0.3758522844788244,"['PRKCG', 'PRKCD', 'FGF1']",0.9934955304449842,0,0,3
161,Adipogenesis WP236,0.6631809641643193,0.8884050959522658,0.3648745280775873,"['CELF1', 'DDIT3', 'PPARA', 'ZMPSTE24']",0.9934955304449842,0,0,4
162,IL-18 signaling pathway WP4754,0.6646454119342071,0.8993917474930133,0.3674029639856272,"['TOMM40', 'GRM7', 'NACA', 'TMSB4X', 'PRKCD', 'CYCS', 'NDUFC1', 'RND2']",0.9934955304449842,0,0,8
163,Alpha 6 Beta 4 signaling pathway WP244,0.664650407903945,0.9631368457659537,0.3934356987200581,['PRKCD'],0.9934955304449842,0,0,1
164,Sphingolipid Metabolism (general overview) WP4725,0.664650407903945,0.9631368457659537,0.3934356987200581,['ASAH1'],0.9934955304449842,0,0,1
165,Sphingolipid Metabolism (integrated pathway) WP4726,0.664650407903945,0.9631368457659537,0.3934356987200581,['ASAH1'],0.9934955304449842,0,0,1
166,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.664650407903945,0.9631368457659537,0.3934356987200581,['IDH3A'],0.9934955304449842,0,0,1
167,Toll-like Receptor Signaling related to MyD88 WP3858,0.664650407903945,0.9631368457659537,0.3934356987200581,['IRF3'],0.9934955304449842,0,0,1
168,TP53 network WP1742,0.664650407903945,0.9631368457659537,0.3934356987200581,['SUMO1'],0.9934955304449842,0,0,1
169,miRNA targets in ECM and membrane receptors WP2911,0.664650407903945,0.9631368457659537,0.3934356987200581,['COL5A1'],0.9934955304449842,0,0,1
170,NOTCH1 regulation of endothelial cell calcification WP3413,0.664650407903945,0.9631368457659537,0.3934356987200581,['LPAR1'],0.9934955304449842,0,0,1
171,Oxidation by Cytochrome P450 WP43,0.664650407903945,0.9631368457659537,0.3934356987200581,['CYP4Z1'],0.9934955304449842,0,0,1
172,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6698255537057618,0.8836573999678612,0.3541150709614126,"['RPS6', 'PRKCD', 'NGF', 'SQSTM1', 'EIF2S1']",0.9934955304449842,0,0,5
173,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.680151969564271,0.8664576802507837,0.3339666001243704,"['PRKCD', 'RPS6']",0.9934955304449842,0,0,2
174,16p11.2 proximal deletion syndrome WP4949,0.6981138802305529,0.8381526307793589,0.3012094566733875,"['TMEM219', 'SEZ6L2', 'CCT7']",0.9934955304449842,0,0,3
175,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6981138802305529,0.8381526307793589,0.3012094566733875,"['HSPA8', 'PSMC5', 'PSMC1']",0.9934955304449842,0,0,3
176,BDNF-TrkB Signaling WP3676,0.6993902794203295,0.8666666666666667,0.30987350585082163,['TRPC3'],0.9934955304449842,0,0,1
177,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6993902794203295,0.8666666666666667,0.30987350585082163,['RPS6'],0.9934955304449842,0,0,1
178,TLR4 Signaling and Tolerance WP3851,0.6993902794203295,0.8666666666666667,0.30987350585082163,['IRF3'],0.9934955304449842,0,0,1
179,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6993902794203295,0.8666666666666667,0.30987350585082163,['BCL6'],0.9934955304449842,0,0,1
180,GDNF/RET signaling axis WP4830,0.6993902794203295,0.8666666666666667,0.30987350585082163,['ROBO2'],0.9934955304449842,0,0,1
181,Methionine De Novo and Salvage Pathway WP3580,0.6993902794203295,0.8666666666666667,0.30987350585082163,['ODC1'],0.9934955304449842,0,0,1
182,Nanoparticle-mediated activation of receptor signaling WP2643,0.6993902794203295,0.8666666666666667,0.30987350585082163,['TLN1'],0.9934955304449842,0,0,1
183,NRF2 pathway WP2884,0.7150492191509249,0.8244983528002396,0.2765399636367599,"['GSTP1', 'BLVRB', 'SQSTM1', 'CES2']",0.9934955304449842,0,0,4
184,The influence of laminopathies on Wnt signaling WP4844,0.7305363660835438,0.7877365201308864,0.24733057163568328,['ZMPSTE24'],0.9934955304449842,0,0,1
185,Gastric Cancer Network 2 WP2363,0.7305363660835438,0.7877365201308864,0.24733057163568328,['OTUD5'],0.9934955304449842,0,0,1
186,Genes controlling nephrogenesis WP4823,0.7305363660835438,0.7877365201308864,0.24733057163568328,['ROBO2'],0.9934955304449842,0,0,1
187,AGE/RAGE pathway WP2324,0.7471345227068489,0.75303257462178,0.21951654549538013,"['PRKCD', 'CYCS']",0.9934955304449842,0,0,2
188,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7471345227068489,0.75303257462178,0.21951654549538013,"['RNF7', 'SQSTM1']",0.9934955304449842,0,0,2
189,Sphingolipid pathway WP1422,0.7584599168812216,0.7219613980177361,0.19959729386558586,['ASAH1'],0.9934955304449842,0,0,1
190,Amyotrophic lateral sclerosis (ALS) WP2447,0.7584599168812216,0.7219613980177361,0.19959729386558586,['TOMM40'],0.9934955304449842,0,0,1
191,Cardiac Progenitor Differentiation WP2406,0.7584599168812216,0.7219613980177361,0.19959729386558586,['SOX2'],0.9934955304449842,0,0,1
192,Differentiation Pathway WP2848,0.7584599168812216,0.7219613980177361,0.19959729386558586,['FGF1'],0.9934955304449842,0,0,1
193,Folate Metabolism WP176,0.7584599168812216,0.7219613980177361,0.19959729386558586,['GPX4'],0.9934955304449842,0,0,1
194,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7584599168812216,0.7219613980177361,0.19959729386558586,['IRF3'],0.9934955304449842,0,0,1
195,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7584599168812216,0.7219613980177361,0.19959729386558586,['DDIT3'],0.9934955304449842,0,0,1
196,IL-2 signaling pathway WP49,0.7584599168812216,0.7219613980177361,0.19959729386558586,['RPS6'],0.9934955304449842,0,0,1
197,Lung fibrosis WP3624,0.7584599168812216,0.7219613980177361,0.19959729386558586,['FGF1'],0.9934955304449842,0,0,1
198,Netrin-UNC5B signaling pathway WP4747,0.7584599168812216,0.7219613980177361,0.19959729386558586,['DAPK1'],0.9934955304449842,0,0,1
199,Nuclear receptors WP170,0.7584599168812216,0.7219613980177361,0.19959729386558586,['PPARA'],0.9934955304449842,0,0,1
200,Oxidative Damage WP3941,0.7584599168812216,0.7219613980177361,0.19959729386558586,['CYCS'],0.9934955304449842,0,0,1
201,22q11.2 copy number variation syndrome WP4657,0.7666236369952925,0.7215256008359456,0.19175213353533488,"['RANBP1', 'MRPL40']",0.9934955304449842,0,0,2
202,Non-small cell lung cancer WP4255,0.7666236369952925,0.7215256008359456,0.19175213353533488,"['PRKCG', 'CYCS']",0.9934955304449842,0,0,2
203,Senescence and Autophagy in Cancer WP615,0.76821277158587,0.7418255214173581,0.19561088709641167,"['GABARAPL1', 'MAP1LC3A', 'SQSTM1']",0.9934955304449842,0,0,3
204,Bladder cancer WP2828,0.7834938838002766,0.6663055254604551,0.1625732334064486,['DAPK1'],0.9934955304449842,0,0,1
205,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7834938838002766,0.6663055254604551,0.1625732334064486,['IRF3'],0.9934955304449842,0,0,1
206,IL-5 signaling pathway WP127,0.7834938838002766,0.6663055254604551,0.1625732334064486,['RPS6'],0.9934955304449842,0,0,1
207,Ebola Virus Pathway on Host WP4217,0.7835095006410323,0.7210884353741497,0.1759254536349272,"['IRF3', 'HLA-B', 'EIF2S1']",0.9934955304449842,0,0,3
208,Pathways Regulating Hippo Signaling WP4540,0.7835095006410323,0.7210884353741497,0.1759254536349272,"['PRKCG', 'PRKCD', 'CDH11']",0.9934955304449842,0,0,3
209,Oncostatin M Signaling Pathway WP2374,0.7847937383053485,0.6925391849529781,0.16782603287269837,"['PRKCD', 'RPS6']",0.9934955304449842,0,0,2
210,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8017087197052201,0.6657824933687002,0.14714454190407922,"['RPS6', 'ZNF516']",0.9934955304449842,0,0,2
211,Type 2 papillary renal cell carcinoma WP4241,0.805936866495198,0.6186004918399285,0.13346297504924648,['ELOB'],0.9934955304449842,0,0,1
212,Interleukin-11 Signaling Pathway WP2332,0.805936866495198,0.6186004918399285,0.13346297504924648,['RPS6'],0.9934955304449842,0,0,1
213,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.805936866495198,0.6186004918399285,0.13346297504924648,['RABAC1'],0.9934955304449842,0,0,1
214,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.805936866495198,0.6186004918399285,0.13346297504924648,['MAP1LC3A'],0.9934955304449842,0,0,1
215,Prader-Willi and Angelman Syndrome WP3998,0.805936866495198,0.6186004918399285,0.13346297504924648,['NGF'],0.9934955304449842,0,0,1
216,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8126816599858204,0.705814401232191,0.14639706450455292,"['SOX2', 'SST', 'NGF', 'SLC25A4']",0.9934955304449842,0,0,4
217,Circadian rhythm related genes WP3594,0.8166600764883379,0.7202099737532809,0.1458658067743865,"['PRKCG', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.9934955304449842,0,0,5
218,Apoptosis WP254,0.8174333846592267,0.6410077789388134,0.12921810834955413,"['IRF3', 'CYCS']",0.9934955304449842,0,0,2
219,Wnt signaling WP428,0.8174333846592267,0.6410077789388134,0.12921810834955413,"['PRKCG', 'DVL3']",0.9934955304449842,0,0,2
220,Joubert Syndrome WP4656,0.8174333846592267,0.6410077789388134,0.12921810834955413,"['CEP120', 'DVL3']",0.9934955304449842,0,0,2
221,Copper homeostasis WP3286,0.8260566518090957,0.5772561293688054,0.11030898329802269,['ATOX1'],0.9934955304449842,0,0,1
222,Vitamin D-sensitive calcium signaling in depression WP4698,0.8260566518090957,0.5772561293688054,0.11030898329802269,['GPX4'],0.9934955304449842,0,0,1
223,p38 MAPK Signaling Pathway WP400,0.8260566518090957,0.5772561293688054,0.11030898329802269,['DDIT3'],0.9934955304449842,0,0,1
224,Pathogenic Escherichia coli infection WP2272,0.8260566518090957,0.5772561293688054,0.11030898329802269,['ARPC3'],0.9934955304449842,0,0,1
225,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8260566518090957,0.5772561293688054,0.11030898329802269,['IRF3'],0.9934955304449842,0,0,1
226,Apoptosis Modulation and Signaling WP1772,0.8320325767720849,0.6180026869682043,0.11364061089636199,"['ENDOG', 'CYCS']",0.9934955304449842,0,0,2
227,Corticotropin-releasing hormone signaling pathway WP2355,0.8320325767720849,0.6180026869682043,0.11364061089636199,"['PRKCD', 'CRH']",0.9934955304449842,0,0,2
228,ESC Pluripotency Pathways WP3931,0.8320325767720849,0.6180026869682043,0.11364061089636199,"['DVL3', 'FGF1']",0.9934955304449842,0,0,2
229,Mesodermal commitment pathway WP2857,0.8365469699736298,0.6485086342229199,0.11574102825610229,"['SOX2', 'ARL4A', 'RPL38']",0.9934955304449842,0,0,3
230,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8440933888883086,0.5410798122065728,0.0917087753714442,['ZMPSTE24'],0.9934955304449842,0,0,1
231,G13 Signaling Pathway WP524,0.8440933888883086,0.5410798122065728,0.0917087753714442,['ARHGDIG'],0.9934955304449842,0,0,1
232,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8440933888883086,0.5410798122065728,0.0917087753714442,['CYCS'],0.9934955304449842,0,0,1
233,Photodynamic therapy-induced unfolded protein response WP3613,0.8440933888883086,0.5410798122065728,0.0917087753714442,['DDIT3'],0.9934955304449842,0,0,1
234,Fragile X Syndrome  WP4549,0.8452383694787613,0.6647314949201741,0.11176569170613022,"['DUSP3', 'ALDH5A1', 'AP2S1', 'AP2M1']",0.9934955304449842,0,0,4
235,ErbB signaling pathway WP673,0.8455704791619937,0.5965841530645336,0.10007326669432842,"['PRKCG', 'ERBB4']",0.9934955304449842,0,0,2
236,Glioblastoma signaling pathways WP2261,0.8455704791619937,0.5965841530645336,0.10007326669432842,"['PRKCG', 'PRKCD']",0.9934955304449842,0,0,2
237,Ectoderm Differentiation WP2858,0.8549757303769026,0.6520707250504332,0.10216787313018044,"['SOX2', 'ARHGDIG', 'DMD', 'MZF1']",0.9934955304449842,0,0,4
238,Myometrial relaxation and contraction pathways WP289,0.8550015023248209,0.6747047244094488,0.1056938802083167,"['PRKCG', 'GSTO1', 'PRKCD', 'LPAR1', 'CRH']",0.9934955304449842,0,0,5
239,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8637468365642379,0.711340206185567,0.10419395956904252,"['COL5A1', 'PIK3IP1', 'PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.9934955304449842,0,0,8
240,Endoderm differentiation WP2853,0.8686087856041531,0.602935270709357,0.08493093596299016,"['SOX2', 'DUSP4', 'TCEAL2']",0.9934955304449842,0,0,3
241,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8747569232463062,0.48078595026951837,0.06433359934989258,['CHP1'],0.9934955304449842,0,0,1
242,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8747569232463062,0.48078595026951837,0.06433359934989258,['MAP1LC3A'],0.9934955304449842,0,0,1
243,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8747569232463062,0.48078595026951837,0.06433359934989258,['DVL3'],0.9934955304449842,0,0,1
244,Nephrotic syndrome WP4758,0.8747569232463062,0.48078595026951837,0.06433359934989258,['ZMPSTE24'],0.9934955304449842,0,0,1
245,Regulation of Actin Cytoskeleton WP51,0.8779928709258996,0.589125160553732,0.07665508366838797,"['TMSB4X', 'BRK1', 'FGF1']",0.9934955304449842,0,0,3
246,Spinal Cord Injury WP2431,0.8804375223045839,0.5403605015673981,0.06880751267873589,"['EFNB2', 'OMG']",0.9934955304449842,0,0,2
247,ATM Signaling Network in Development and Disease  WP3878,0.88775003028139,0.45539906103286387,0.054222122468174955,['DCLRE1C'],0.9934955304449842,0,0,1
248,Common Pathways Underlying Drug Addiction WP2636,0.88775003028139,0.45539906103286387,0.054222122468174955,['PRKCG'],0.9934955304449842,0,0,1
249,"GPCRs, Other WP117",0.88775003028139,0.45539906103286387,0.054222122468174955,['GPR61'],0.9934955304449842,0,0,1
250,Kit receptor signaling pathway WP304,0.88775003028139,0.45539906103286387,0.054222122468174955,['RPS6'],0.9934955304449842,0,0,1
251,PPAR signaling pathway WP3942,0.88775003028139,0.45539906103286387,0.054222122468174955,['PPARA'],0.9934955304449842,0,0,1
252,Androgen receptor signaling pathway WP138,0.8903418410149309,0.5238909470884392,0.060849828187581216,"['SUMO1', 'PARK7']",0.9934955304449842,0,0,2
253,B Cell Receptor Signaling Pathway WP23,0.8903418410149309,0.5238909470884392,0.060849828187581216,"['BCL6', 'PRKCD']",0.9934955304449842,0,0,2
254,Interferon type I signaling pathways WP585,0.8993970568602546,0.4325508607198748,0.045863660593747003,['RPS6'],0.9934955304449842,0,0,1
255,Notch Signaling Pathway Netpath WP61,0.8993970568602546,0.4325508607198748,0.045863660593747003,['APH1A'],0.9934955304449842,0,0,1
256,Proximal tubule transport WP4917,0.8993970568602546,0.4325508607198748,0.045863660593747003,['ATP6V1F'],0.9934955304449842,0,0,1
257,RANKL/RANK signaling pathway WP2018,0.8993970568602546,0.4325508607198748,0.045863660593747003,['SQSTM1'],0.9934955304449842,0,0,1
258,Rett syndrome causing genes WP4312,0.8993970568602546,0.4325508607198748,0.045863660593747003,['GPS2'],0.9934955304449842,0,0,1
259,Thermogenesis WP4321,0.8994802838663494,0.5083901899317721,0.0538579135681739,"['RPS6', 'ZNF516']",0.9934955304449842,0,0,2
260,DNA damage response (only ATM dependent) WP710,0.8994802838663494,0.5083901899317721,0.0538579135681739,"['BCL6', 'DVL3']",0.9934955304449842,0,0,2
261,G Protein Signaling Pathways WP35,0.9079050324328035,0.49377519032691447,0.047706334769133794,"['PRKCG', 'PRKCD']",0.9934955304449842,0,0,2
262,Integrated breast cancer pathway WP1984,0.9098354108443788,0.5396389324960753,0.05099132620537308,"['FER', 'ODC1', 'FAU']",0.9934955304449842,0,0,3
263,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9098372603406211,0.4118786794843133,0.03891822294636411,['DCLRE1C'],0.9934955304449842,0,0,1
264,DNA damage response WP707,0.9191955115659055,0.39308578745198464,0.033120007272158636,['CYCS'],0.9934955304449842,0,0,1
265,Endometrial cancer WP4155,0.9191955115659055,0.39308578745198464,0.033120007272158636,['FGF1'],0.9934955304449842,0,0,1
266,IL-1 signaling pathway WP195,0.9191955115659055,0.39308578745198464,0.033120007272158636,['SQSTM1'],0.9934955304449842,0,0,1
267,MET in type 1 papillary renal cell carcinoma WP4205,0.9191955115659055,0.39308578745198464,0.033120007272158636,['RPL11'],0.9934955304449842,0,0,1
268,Focal Adhesion WP306,0.9213569485372204,0.5565023331304524,0.04558185483262765,"['PRKCG', 'PDGFC', 'VEGFB', 'TLN1']",0.9934955304449842,0,0,4
269,TGF-beta Signaling Pathway WP366,0.9228092357233834,0.46691519105312207,0.03750857868212422,"['PARD6A', 'SUMO1']",0.9934955304449842,0,0,2
270,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9275837791583967,0.3759270599442063,0.028259249341412464,['DVL3'],0.9934955304449842,0,0,1
271,miRNA regulation of DNA damage response WP1530,0.9275837791583967,0.3759270599442063,0.028259249341412464,['CYCS'],0.9934955304449842,0,0,1
272,Neural Crest Differentiation WP2064,0.9275837791583967,0.3759270599442063,0.028259249341412464,['DVL3'],0.9934955304449842,0,0,1
273,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9275837791583967,0.3759270599442063,0.028259249341412464,['TLN1'],0.9934955304449842,0,0,1
274,Prolactin Signaling Pathway WP2037,0.9275837791583967,0.3759270599442063,0.028259249341412464,['RPS6'],0.9934955304449842,0,0,1
275,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9275837791583967,0.3759270599442063,0.028259249341412464,['ANGPTL1'],0.9934955304449842,0,0,1
276,Insulin Signaling WP481,0.9339524109624915,0.4977659702934428,0.034012246166394415,"['PRKCD', 'ENPP1', 'STX4']",0.9934955304449842,0,0,3
277,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9351024606421509,0.3601982263954095,0.024169002791232307,['CYCS'],0.9934955304449842,0,0,1
278,Breast cancer pathway WP4262,0.9354200309116669,0.4428100634997187,0.02956183141461019,"['DVL3', 'FGF1']",0.9934955304449842,0,0,2
279,Hepatitis B infection WP4666,0.9389739385736652,0.4882852996060543,0.0307461312665818,"['PRKCG', 'IRF3', 'CYCS']",0.9934955304449842,0,0,3
280,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9418415765110608,0.3457276995305164,0.020715380184334175,['DMD'],0.9934955304449842,0,0,1
281,Nuclear Receptors Meta-Pathway WP2882,0.9452129882271054,0.567511353000312,0.03197642293773362,"['PSMC5', 'GSTP1', 'BLVRB', 'PPARA', 'SQSTM1', 'CES2']",0.9934955304449842,0,0,6
282,T-cell receptor (TCR) signaling pathway WP69,0.9478818414492649,0.332370290116769,0.017790260808782623,['PRKCD'],0.9934955304449842,0,0,1
283,Toll-like Receptor Signaling Pathway WP75,0.9478818414492649,0.332370290116769,0.017790260808782623,['IRF3'],0.9934955304449842,0,0,1
284,Vitamin D Receptor Pathway WP2877,0.9507356611315957,0.4109568592327213,0.020761217486193247,"['BCL6', 'CLPTM1L']",0.9934955304449842,0,0,2
285,Gastrin signaling pathway WP4659,0.9507356611315957,0.4109568592327213,0.020761217486193247,"['RPS6', 'PRKCD']",0.9934955304449842,0,0,2
286,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9532956248076766,0.3200023184373732,0.015305780976546954,['RPS6'],0.9934955304449842,0,0,1
287,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9532956248076766,0.3200023184373732,0.015305780976546954,['ENPP1'],0.9934955304449842,0,0,1
288,Endochondral Ossification WP474,0.9532956248076766,0.3200023184373732,0.015305780976546954,['ENPP1'],0.9934955304449842,0,0,1
289,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9581478122631465,0.3085177733065057,0.013190128348041338,['EIF2B5'],0.9934955304449842,0,0,1
290,PI3K-Akt signaling pathway WP4172,0.9603662959774761,0.5374605678233438,0.021735178922274685,"['PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.9934955304449842,0,0,6
291,Head and Neck Squamous Cell Carcinoma WP4674,0.9624965787257777,0.29782526577087043,0.011384301509081698,['RPS6'],0.9934955304449842,0,0,1
292,Melanoma WP4685,0.9624965787257777,0.29782526577087043,0.011384301509081698,['ERBB4'],0.9934955304449842,0,0,1
293,Chemokine signaling pathway WP3929,0.9658414493391277,0.3749488891917678,0.013031569623557455,"['PRKCD', 'RASGRP2']",0.9934955304449842,0,0,2
294,DNA IR-damage and cellular response via ATR WP4016,0.9663940811927383,0.2878455920709442,0.009839591791975471,['BCL6'],0.9934955304449842,0,0,1
295,Leptin signaling pathway WP2034,0.9698870806690018,0.2785097682871422,0.008515610496484388,['RPS6'],0.9934955304449842,0,0,1
296,Small cell lung cancer WP4658,0.9730174993663123,0.26975743348982784,0.007378732266181322,['CYCS'],0.9934955304449842,0,0,1
297,Integrin-mediated Cell Adhesion WP185,0.9758229209709735,0.26153554322568406,0.006400858143640806,['TLN1'],0.9934955304449842,0,0,1
298,Pancreatic adenocarcinoma pathway WP4263,0.9758229209709735,0.26153554322568406,0.006400858143640806,['PRKCD'],0.9934955304449842,0,0,1
299,Calcium Regulation in the Cardiac Cell WP536,0.9771551434310864,0.3972708610071247,0.009180867549377551,"['PRKCG', 'PRKCD', 'ATP1B2']",0.9934955304449842,0,0,3
300,"GPCRs, Class A Rhodopsin-like WP455",0.9844183064497463,0.23309224717675422,0.003660565514385559,['MCHR1'],0.9953424330411839,0,0,1
301,Genes related to primary cilium development (based on CRISPR) WP4536,0.9860395686354512,0.2269170579029734,0.0031901803361571415,['CEP120'],0.9953424330411839,0,0,1
302,Hippo-Merlin Signaling Dysregulation WP4541,0.9887941275606498,0.21549295774647886,0.002428418424726748,['CDH11'],0.9953424330411839,0,0,1
303,Ras signaling WP4223,0.9931596271853249,0.27292630740906604,0.0018733321684649678,"['PRKCG', 'RASGRP2']",0.9957898918280124,0,0,2
304,Ciliopathies WP4803,0.9957898918280124,0.2526276968467638,0.0010658351492521098,"['CEP120', 'PKD1L1']",0.9957898918280124,0,0,2
